We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biogeneric Bill Approval, Multiple Regulations Likely, U.S. Official Predicts
Biogeneric Bill Approval, Multiple Regulations Likely, U.S. Official Predicts
March 15, 2007
A biogeneric approval mechanism may lead regulators to create separate rules for these types of treatments, according to former U.S. Centers for Medicare & Medicaid Services (CMS) Administrator Mark McClellan, who said he is optimistic that the U.S. Congress will pass legislation this year easing the entry of follow-on biologics.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor